OLR1 antibody (PE)
Quick Overview for OLR1 antibody (PE) (ABIN705231)
Target
See all OLR1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Excitation / Emission Wavelengths: 565nm/578nm
-
Cross-Reactivity
- Rat (Rattus), Pig (Porcine), Cow (Bovine)
-
Purification
- purified by Protein A
-
Immunogen
- KLH conjugated synthetic peptide derived from human sLOX 1
-
Isotype
- IgG
-
-
-
-
Comment
-
Excitation / Emission wavelength: 496nm / 578nm
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 µg/µL
-
Buffer
- Aqueous buffered solution containing 100 µg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4 °C for 12 months
-
Expiry Date
- 12 months
-
-
- OLR1 (Oxidized Low Density Lipoprotein (Lectin-Like) Receptor 1 (OLR1))
-
Alternative Name
- sLOX 1
-
Background
- Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis. Its association with oxLDL induces the activation of NF-kappa-B through an increased production of intracellular reactive oxygen and a variety of pro-atherogenic cellular responses including a reduction of nitric oxide (NO) release, monocyte adhesion and apoptosis. In addition to binding oxLDL, it acts as a receptor for the HSP70 protein involved in antigen cross-presentation to naive T-cells in dendritic cells, thereby participating in cell-mediated antigen cross-presentation. Also involved in inflammatory process, by acting as a leukocyte-adhesion molecule at the vascular interface in endotoxin-induced inflammation. Also acts as a receptor for advanced glycation end (AGE) products, activated platelets, monocytes, apoptotic cells and both Gram-negative and Gram-positive bacteria.
-
Molecular Weight
- 31kDa
-
Gene ID
- 4973
Target
-